[Combined alclofenac-bufexamac in rheumatology].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000498:Allyl Compounds / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D004357:Drug Synergism; D004987:Ethers / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006877:Hydroxamic Acids / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009437:Neuralgia / Q000188:drug therapy; D009443:Neuritis / Q000188:drug therapy; D010489:Periarthritis / Q000188:drug therapy; D010648:Phenylacetates / Q000008:administration & dosage / Q000627:therapeutic use*; D012216:Rheumatic Diseases / Q000188:drug therapy*
D000498:Allyl Compounds; D000700:Analgesics; D000893:Anti-Inflammatory Agents; D004987:Ethers; D006877:Hydroxamic Acids; D010648:Phenylacetates
L'association alslofenac-bufexamac en rhumatologie.